Sponsor:
UCLA
Code:
NCT05009992
Conditions
Diffuse Intrinsic Pontine Glioma
Diffuse Midline Glioma, H3 K27M-Mutant
Recurrent Diffuse Intrinsic Pontine Glioma
Recurrent Diffuse Midline Glioma, H3 K27M-Mutant
Recurrent WHO Grade III Glioma
Eligibility Criteria
Sex: All
Age: 2 - 39
Healthy Volunteers: Not accepted
Interventions
ONC201
Radiation Therapy
Paxalisib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-29. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2025-03-25.